Cancer UK partners with Guardant to advance cancer drugs and diagnostics
The agreement allows Guardant Health to leverage Cancer Research UK’s network to validate its technologies.
RWS WP
Bayer and Recursion expand oncology research partnership
Signal: Project NextGen continues with $500m funding for vaccine research
Immetas and GC Biopharma team up for mRNA therapeutic research
TREAT California embarks on plan to earn $5bn for psychedelic research
Researchers publish early results with new interleukin-targeting antibody
Researchers find potential association between cadmium and endometriosis
Twist and Cancer Research Horizons sign antibody library platform deal
